Skip to main content

Torley Helen's Form 4 filing

Halozyme Therapeutics, Inc. (HALO) · filed Jul 10, 2025

Accession no.
0001415889-25-019653
Filed
Jul 10, 2025
Trade date
Jul 8-10, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 9 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.39M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Torley HelenCIK 0001528185Director, Officer (PRESIDENT AND CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 8, 2025Common StockMOption exerciseAcquired+20,000$8.11+$162,200753,719Direct
Jul 8, 2025Common StockSSaleDisposed−3,598$54.48−$196,019.04750,121Direct
Jul 8, 2025Common StockSSaleDisposed−16,402$55.74−$914,247.48733,719Direct
Jul 9, 2025Common StockMOption exerciseAcquired+20,000$8.11+$162,200753,719Direct
Jul 9, 2025Common StockSSaleDisposed−19,792$56.43−$1,116,862.56733,927Direct
Jul 9, 2025Common StockSSaleDisposed−208$57.08−$11,872.64733,719Direct
Jul 10, 2025Common StockMOption exerciseAcquired+20,000$8.11+$162,200753,719Direct
Jul 10, 2025Common StockSSaleDisposed−4,254$56.74−$241,371.96749,465Direct
Jul 10, 2025Common StockSSaleDisposed−15,746$57.62−$907,284.52733,719Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 8, 2025Common StockMOption exerciseDisposed−20,000$8.11−$162,200296,569Direct
Jul 9, 2025Common StockMOption exerciseDisposed−20,000$8.11−$162,200276,569Direct
Jul 10, 2025Common StockMOption exerciseDisposed−20,000$8.11−$162,200256,569Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)